The super-sized gathering of the biopharma universe known as JPM is important, but it’s not going to make or break the year for biotech, Adam Feuerstein writes.
Private biotechs raised $1B+ pre-JPM conference, led by Parabilis' $305M Series F. Public companies like Arrowhead ($625M) & Alumis ($300M) also secured funding amid sector optimism.
Some lawmakers will meet on Thursday to discuss and edit draft legislation on crypto market structure, with the aim of passing a comprehensive law this year.
President Donald Trump, like any politician whose polling is in the gutter, is desperate for a villain — any villain — to blame for America’s affordability woes. Enter Wall Street.
The 2026 Social Security COLA is finalized and retirees will start getting their checks this month -- but unfortunately, they're taking a major financial hit.
"2026 is the year of more widespread adoption of AI tools, particularly in hiring," Janine Chamberlin, LinkedIn's UK Country Manager told CNBC Make It.